Overcoming Disparities in Depression Care
With Psychotherapy
Module 1: Referring medical patients to psychotherapy
Module 2: Does psychotherapy treat depression in primary care patients?
Module 3: Bringing depression care to low-income and minority patients
Introduction
Jeanne Miranda, PhD, Professor, Department of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute begins her presentation by providing case examples of the application of the four evidence-based forms of psychotherapy: cognitive-behavioral therapy, behavioral therapy, interpersonal psychotherapy, and problem solving therapy and how these therapies work. Dr. Miranda goes on to cover approaches to referral and examines the outcomes of evidence-based therapies in minority patient populations.
Intended Audience
This continuing medical education program is intended for primary care physicians and other healthcare professionals who manage patients with depressive disorders.
Educational Objectives
After completing this activity, participants should be better able to:
- Describe the role of psychotherapy in treating depression
- Review the evidence-based psychotherapies in the treatment of depression
- Discuss how to make an effective referral for psychotherapy
- Identify the types of depression in which psychotherapy is effective
- Explain how the different forms of psychotherapy (i.e., CBT, BT, IPT, PST) work
- Describe what psychotherapy adds to depression care
- Examine the outcomes of evidence-based therapies in minority patients
Information on CME credit
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Medical Association designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Instructions for CME credit
This online enduring material is presented as an audio webcast with attendant slide presentation. To receive credit, please listen to and view all of the presentations of this CME activity and evaluate the content presented. Complete both the pre- and post-test and activity evaluation.
The estimated time to complete this activity, including pre-test, review of the materials, and self-assessment and evaluation is 1.0 hour.
Principal Faculty
Wayne Katon, MD, Planning Committee Chair, Content Reviewer
Professor and Vice Chair
Department of Psychiatry and Behavioral Sciences
Director, Division of Health Services and Psychiatric Epidemiology
University of Washington School of Medicine
Seattle, WA
Michael S. Klinkman, MD, Planning Committee, Content Reviewer
Associate Professor, Department of Medicine
Associate Professor, Department of Psychiatry
Department of Family Medicine
Director, Primary Care Programs
University of Michigan Depression Center
Ann Arbor, MI
Kurt Kroenke, MD, Planning Committee, Content Reviewer
Professor of Medicine
Indiana University School of Medicine
Research Scientist, Regenstrief Institute, Inc.
Indianapolis, IN
Jeanne Miranda, PhD, Author/Presenter
Professor
Department of Psychiatry and Biobehavioral Sciences
UCLA Neuropsychiatric Institute
Los Angeles, CA
John Williams, MD, Planning Committee, Content Reviewer
Associate Professor of Medicine and Psychiatry
General Medicine
Duke University School of Medicine
Durham, NC
R. Mark Evans, PhD, Planning Committee,
Director, Healthcare Education Products and Standards
American Medical Association
Chicago, IL
Kristi Eidsvoog, PhD, Planning Committee,
Content Manager
MedEd Architects, LLC
Chicago, IL
Patti Fitzgerald, Planning Committee
Manager, Product Development, Healthcare Education Products and Standards
American Medical Association
Chicago, IL
Faculty
Disclosure Policy
In order to assure the highest quality of CME programming, and to comply with the ACCME Standards for Commercial Support, the AMA requires that all faculty and planning committee members disclose relevant financial relationships with any commercial or proprietary entity producing health care goods or services relevant to the content being presented. We therefore obtain a completed disclosure and attestation form to inform the participant of any pertinent relationships disclosed, provided here.
These materials have been peer-reviewed by the members of the AMAprimarycare Depression Planning Committee to ensure the continued scientific accuracy and medical relevance of information presented and its independence from commercial bias. The AMA has control over all final content.
Dr. Katon: Advisory Board, Lilly, Wyeth; Speakers Bureau, Pfizer, Forest, GlaxoSmithKline
Dr. Klinkman: Advisory Board, Wyeth; Research Grant, Lilly; Independent Contractor, GE/Healthology
Dr. Kroenke: Research Grant, Lilly, Pfizer, Wyeth; Consultant, Lilly, Pfizer, Wyeth
Dr. Williams: Nothing relevant to disclose
Dr. Miranda: Nothing relevant to disclose
Dr. Evans: Nothing relevant to disclose
Dr. Eidsvoog: Nothing relevant to disclose
Ms. Fitzgerald: Nothing relevant to disclose
Acknowledgement of Support
This CME publication was supported through an independent education grant from Eli Lilly & Company and produced in accordance with the AMA Standards for Industry-Supported Multimedia Continuing Medical Education and Other Communications.
Term of approval
Original Release Date- September 2008
Date of Most Recent Review- December 2009
Expiration Date- December 2010
